Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Expanded_access × Imatinib Mesylate × Gastrointestinal × Clear all

Status

No longer available 1

Sponsor Class

Study Type

Interventional 83 Observational 3 Expanded_access 1

Sponsor

Cancer Type

Sarcoma 1 Other hematologic neoplasm 1 Myeloid 1 Gastrointestinal 1

Conditions

Gastrointestinal Stromal Tumors 1

Interventions

regorafenib 3 Sunitinib 2 Ramucirumab 2 Oxaliplatin 2 Fluorouracil 2 zenocutuzumab 1 zanidatamab 1 ulixertinib 1 trifluridine tipiracil drug combination 1 sodium thiosulfate 1 selpercatinib 1 ripretinib 1 peginterferon alfa-2a 1 pegilodecakin 1 onvansertib 1 omburtamab I-131 1 guselkumab 1 futibatinib 1 derazantinib 1 balstilimab 1 avapritinib 1 Tenofovir 1 Taxes 1 Proton Pump Inhibitors 1 Paclitaxel 1 Melphalan 1 Leucovorin 1 Laparoscopy 1 Imatinib Mesylate 1 IMM-101 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01613053 2015-04-24

MACS2226

Novartis

No longer available

GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡